Feng Gu
Impact in
-
- Pituitary Gland Disorders and Treatments
- Adrenal Hormones and Disorders
- Growth Hormone and Insulin-like Growth Factors
-
- Adrenal and Paraganglionic Tumors
Papers in
-
- Pituitary Gland Disorders and Treatments 10
- Growth Hormone and Insulin-like Growth Factors 5
- Surgery 6
- Adrenal and Paraganglionic Tumors 6
- Co-authors
- Mario Maldonado (2 shared papers)Annamaria Colao (3 shared papers)John Newell‐Price (6 shared papers)Stephan Petersenn (4 shared papers)Beverly M. K. Biller (5 shared papers)James W. Findling (5 shared papers)U Schoenherr (3 shared papers)David Mills (2 shared papers)
- Journals
- Clinical Endocrinology (1 paper)Frontiers in Cardiovascular Medicine (1 paper)Medicine (1 paper)npj Digital Medicine (1 paper)Frontiers in Cellular and Infection Microbiology (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Feng Gu
20 papers receiving 702 citations
Feng Gu's Hit Papers
Peers
Comparison fields: 5 of 62
- Endocrinology, Diabetes and Metabolism 549
- Surgery 223
- Genetics 46
- Epidemiology 129
- Applied Microbiology and Biotechnology 6
Countries citing papers authored by Feng Gu
This map shows the geographic impact of Feng Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Gu more than expected).
Fields of papers citing papers by Feng Gu
This network shows the impact of papers produced by Feng Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Gu. The network helps show where Feng Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease Hit paper breakdown → | 2012 | 495 |
| 2 | 2013 | 108 | |
| 3 | 2021 | 37 | |
| 4 | 2022 | 19 | |
| 5 | Pasireotide LAR is significantly more effective than octreotide LAR at inducing biochemical control in patients with acromegaly: results of a 12-month randomized, double-blind, multicenter, Phase III study | 2012 | 12 |
| 6 | 2020 | 12 | |
| 7 | 2022 | 10 | |
| 8 | 2025 | 9 | |
| 9 | 2010 | 9 | |
| 10 | 2013 | 7 | |
| 11 | 2015 | 6 | |
| 12 | Pasireotide treatment is associated with improvements in hypertension: 12-month results from a large phase III study in Cushing's disease | 2012 | 4 |
| 13 | Pasireotide LAR vs octreotide LAR in patients with acromegaly: double-blind, crossover, extension period to a randomized, double-blind, multicenter, phase III study | 2012 | 3 |
| 14 | 2023 | 3 | |
| 15 | 2025 | 2 | |
| 16 | Pasireotide (SOM230) demonstrates efficacy in patients with Cushing's disease: results from a large, randomized-dose, double-blind, Phase III study | 2011 | 2 |
| 17 | 2021 | 1 | |
| 18 | [Thyroid-stimulating hormone pituitary adenomas: clinical characteristics, diagnosis and treatment]. | 2011 | 1 |
| 19 | 2025 | 1 | |
| 20 | 2019 | 1 |
About Feng Gu
Feng Gu is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Cardiology and Cardiovascular Medicine, Epidemiology and Infectious Diseases, having authored 23 papers that have together received 742 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (10 papers), Adrenal and Paraganglionic Tumors (6 papers), Growth Hormone and Insulin-like Growth Factors (5 papers), Aortic Disease and Treatment Approaches (2 papers), Antifungal resistance and susceptibility (2 papers), Fungal Infections and Studies (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and Parathyroid Disorders and Treatments (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (549 citations), Surgery (223 citations), Genetics (46 citations), Epidemiology (129 citations) and Applied Microbiology and Biotechnology (6 citations). Feng Gu has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Mario Maldonado, Annamaria Colao, John Newell‐Price, Stephan Petersenn, Beverly M. K. Biller, James W. Findling, U Schoenherr, David Mills, Luiz Roberto Salgado and L R Salgado. Their work appears in journals such as Clinical Endocrinology, Frontiers in Cardiovascular Medicine, Medicine, npj Digital Medicine and Frontiers in Cellular and Infection Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.